Tetsuo Machida

Tetsuo Machida

Auto-generated profile, based on publicly available information

Tetsuo Machida

Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SSSuman Shrestha
Suman Shrestha
HSHiroaki Sunaga
Hiroaki Sunaga
HHHirofumi Hanaoka
Hirofumi Hanaoka
AYAiko Yamaguchi
Aiko Yamaguchi
SKShoji Kuwahara
Shoji Kuwahara
Tatsuya IsoTatsuya Iso
Tatsuya Iso
Circulating fatty acid binding protein 4 (FABP4), secreted from adipocytes, is a potential biomarker for metabolic and cardiovascular diseases. Circulating FABP4 levels are positively associated with adiposity and adrenergic stimulation, but negatively with renal function. In this study, we addressed the issue of how the kidney regulates clearance of circulating FABP4. Tracing study revealed remarkable accumulation of 125I-labeled FABP4 in the kidney. Exogenous FABP4 was exclusively detected in the apical membrane of proximal tubule epithelial cells (PTECs). Bilateral nephrectomy resulted in marked elevation of circulating FABP4 levels. Accelerated lipolysis by β-3 adrenergic stimulation led to a marked elevation in circulating FABP4 in mice with severe renal dysfunction. Megalin, an endocytic receptor expressed in PTECs, plays a major role in reabsorption of proteins filtered through glomeruli. Quartz-crystal microbalance study revealed that FABP4 binds to megalin. In kidney-specific megalin knockout mice, a large amount of FABP4 was excreted in urine while circulating FABP4 levels were significantly reduced. Our data suggest that circulating FABP4 is processed by the kidney via the glomerular filtration followed by megalin-mediated reabsorption. Thus, it is likely that circulating FABP4 levels are determined mainly by balance between secretion rate of FABP4 from adipocytes and clearance rate of the kidney.

1 January 2015 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KKKoji Kikkawa
Koji Kikkawa
KNKatsuyuki Nakajima
Katsuyuki Nakajima
YSYounosuke Shimomura
Younosuke Shimomura
YTYoshiharu Tokita
Yoshiharu Tokita
TMTetsuo Machida
Tetsuo Machida
MMMasami Murakami
Masami Murakami

1 January 2018 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
KMKazuya Miyashita
Kazuya Miyashita
IFIsamu Fukamachi
Isamu Fukamachi
MNManabu Nagao
Manabu Nagao
TITatsuro Ishida
Tatsuro Ishida
JKJunji Kobayashi
Junji Kobayashi
KNKatsuyuki Nakajima
Katsuyuki Nakajima

1 November 2017 in Clinical Biochemistry
Verified
Journal Article
Open access
Tatsuya IsoTatsuya Iso
Tatsuya Iso
HSHiroaki Sunaga
Hiroaki Sunaga
HMHiroki Matsui
Hiroki Matsui
SKShu Kasama
Shu Kasama
NONaomi Oshima
Naomi Oshima
MKMasahiko Kurabayashi
Masahiko Kurabayashi
Background: Lipolysis is stimulated by activation of adrenergic inputs to adipose tissues. Our recent study showed that serum concentrations of fatty acid binding protein 4 (FABP4) are robustly elevated in patients with acute myocardial infarction and ventricular tachyarrhythmia, that display a marked activation of the sympathetic nervous system (SNS). However, it remains unknown whether circulating FABP4 concentrations are associated with exercise-induced SNS activation. Methods: Thirty one healthy volunteers underwent cardiopulmonary exercise testing on a cycle ergometer up to the workload levels below and above anaerobic threshold, low- and high-intensity exercise, respectively. Serial blood samplings were performed before and after exercise. Results: High-intensity exercise significantly increased serum concentrations of FABP4 and catecholamines, and their concentrations declined fast thereafter in a similar fashion. These changes were accompanied by little, if any, changes in other metabolic markers. Regardless of adiposity, percent change from baseline to peak FABP4 levels (%FABP4) was comparable in all subjects. Stepwise regression analysis revealed that %FABP4 was highly correlated with that in norepinephrine. Conclusions: Our study reveals the significant correlation between circulating FABP4 and norepinephrine levels during exercise testing. Together with the fact that FABP4 is secreted from adipocytes via beta-adrenergic-mediated lipolytic mechanisms, this study suggests FABP4 as a potential biomarker for adrenergic overdrive.

1 December 2018 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KMKazuya Miyashita
Kazuya Miyashita
IFIsamu Fukamachi
Isamu Fukamachi
TMTetsuo Machida
Tetsuo Machida
KNKiyomi Nakajima
Kiyomi Nakajima
SYStephen G. Young
Stephen G. Young
KNKatsuyuki Nakajima
Katsuyuki Nakajima

1 December 2018 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KNKiyomi Nakajima
Kiyomi Nakajima
TMTetsuo Machida
Tetsuo Machida
SIShigeyuki Imamura
Shigeyuki Imamura
DKDaisuke Kawase
Daisuke Kawase
KMKazuya Miyashita
Kazuya Miyashita
MMMasami Murakami
Masami Murakami